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Spinal cord stimulation (SCS) is used to manage chronic pain syndromes and it is accepted a cost-effective 
therapy. Child-bearing women who had SCS become or choose to become pregnant despite these policies 
pregnancy is a relative contraindication. A 32-year-old woman had SCS as a treatment for the CRPS I of the 
left lower extremity. During various check up tests, we happen to find out that her serum beta-hCG was positive 
and confirmed pregnancy. SCS is not recommended in pregnancy because the effects of SCS on pregnancy 
and nursing mothers had not been confirmed. However, many female patients suffering from chronic pain may 
expect future pregnancy and we think that they must be informed about the possibility of pregnancy and the 
effects of SCS device implantation in the course of pregnancy. First of all, a good outcome requires a 
multidisciplinary team approach, including obstetrics, neonatology, pain medicine and anesthesia, as was used 
from an early pregnancy. Unfortunately, she had a misabortrion after 6 weeks. (Korean  J  Pain  2010;  23: 
266-269)
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    Spinal cord stimulation (SCS) is becoming an increas-
ingl y po p u l ar m e th od f o r th e t r eatm en t o f c hr o n i c  pain 
syndromes, including diabetic neuropathy, failed back sur-
gery syndrome, complex regional pain syndrome, chronic 
arachnoiditis, phantom limb pain, ischemic limb pain, re-
fractory  unilateral  limb  pain  syndrome,  angina,  post-
herpetic neuralgia and acute herpes zoster pain. The goal 
of the treatment is not a cure, but a therapeutic option 
that can significantly reduce pain and improve the quality 
of life for most patients. In addition, SCS has been proved 
to reduce the typical medication dose needed [1,2]. It is now 
widely used for a number of indications (over 14,000 SCS 
implantations  occur  annually  world-wide  [3]).  Given  the 
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used more frequently in parturient care. We report a rare 
case of pregnancy in a woman with a spinal cord stim-
ulator and review the literature on pregnancy in women 
with SCS.
CASE  REPORT
    A 32-year-old woman with SCS presented for con-
sultation in court regarding documentation concerning her 
injuries related to a traffic accident she had experienced. 
S h e  h a d  r e c e i v e d  S C S  i m p l a n t a t i o n  a t  a n o t h e r  h o s p i t a l  
several months earlier as treatment for CRPS I of the left 
lower extremity. Her chronic pain syndrome stemmed from 
the  unfortunate  complications  of  a  previous  pedestrian 
traffic accident in which she was struck on the backside 
by a car. Lumbar spine X-rays and MRI were within nor-
mal limits, but she suffered from allodynia, hyperalgesia, 
motor weakness and temperature fluctuations at that time. 
Despite  extensive  physical  therapy,  anxiolytic  therapy, 
several local anesthetic blocks, four sympathetic blocks, 
transcutaneous electric stimulation and adjunctive phar-
macological management, her condition failed to improve. 
During the early period of SCS implantation, her pain was 
reduced to an acceptable level, but when she presented for 
consultation  at  our  hospital,  she  clearly  required  pain 
relief. The electrodes entered the L3-4 interspace, and the 
end of the electrode was located in the epidural space at 
the T9-10. The generator was then implanted in the ante-
rior abdominal wall. At the time of her visit to our pain clin-
ic, she was receiving propranolol HCl 20 mg, mirtazapine 
30 mg and tramadol HCl 50 mg twice a day, along with 
buspirone HCl 15 mg, solifenacin succinate 5 mg, mefe-
namic acid 250 mg, ethyl loflazepate 1 mg and sodium tia-
neptine 12.5 mg daily. During various checkup tests, we 
found that her urine beta-hCG was positive, which is the 
case in women of childbearing age. Thus, her serum be-
ta-hCG was checked, revealing that it was 150.19 mIU/ml. 
Immediately, we consulted the obstetric department, and 
eventually pregnancy was diagnosed, but ultrasonographic 
v i s u a l i z a t i o n  d i d  n o t  r u l e  o u t  t h e  p o s s i b i l i t y  o f  e c t o p i c  
p r e g n a n c y ,  a  t u b a l  a b o r t i o n  s t a t e  o r ,  l e s s  l i k e l y ,  e a r l y 
pregnancy. She was informed about this and further tests 
were recommended. However, she quit her therapy at our 
hospital and transferred to a hospital closer to her home 
for the management required. Upon her discharge, we in-
formed her that there were no animal or human studies 
regarding  possible  teratogenic  effects  or  fetal/maternal 
risk of using SCS at the time of conception, pregnancy, 
or labor. We also explained that despite all the risks, preg-
nancy is possible if she desired and recommended that a 
good outcome requires a multidisciplinary team approach, 
including obstetrics, neonatology, pain medicine and anes-
thesia, as was used in an early pregnancy. Unfortunately, 
she had a missed abortion after 6 weeks.
DISCUSSION
    Management of patients with chronic pain syndromes 
during pregnancy can be challenging, particularly in the 
presence of SCS. SCS is an accepted cost-effective ther-
apy for many chronic pain syndromes. The safety and ef-
fects of SCS during pregnancy have not been established, 
and pregnancy is a relative contraindication according to 
the FDA and the manufacturers of the related devices [4]. 
Various meta-analysis and reviews of the effects of SCS 
have not included this group of patients [2,5,6]. However, 
SCS is increasingly used to manage chronic pain in a fe-
male in her reproductive years may present. Child-bearing 
women who had SCS become or choose to become preg-
nant despite these policies. 
    Reviewing the literature in English, we f ound f our case 
reports  of  SCS  in  pregnancy.  In  the  first  case,  a  31- 
year-old woman with cervical SCS of CRPS II allowed po-
tentially teratogenic painkillers to be discontinued before 
conception. The cervical SCS electrode end was in the epi-
dural space at the C2-3 interspace, and the generator was 
implanted in the upper gluteal region instead of the abdo-
men owing to the patient’s concern of discomfort during 
pregnancy and the risk of damage if a caesarean section 
was necessary. This patient had a full-term safe vaginal 
delivery despite the SCS being turned off the time of labor 
and delivery. The disadvantages of using teratogenic an-
algesics were overcome by SCS [7]. In the second case, 
a 37-year-old woman with cervical SCS of CRPS I pre-
sented for epidural analgesia for labor. She was taking no 
medication. The electrodes entered the C7-T1 interspace 
and the ends of electrodes were located in epidural space 
at the C3 level. The generator was implanted in the left 
l o w e r  b u t t o c k .  T h e  s p i n a l  c o r d  s t i m u l a t o r  c o n t i n u e d  t o  
function well throughout the entire process. A year and a 
half later, particularly interesting, the same patient pre-
sented again to their labor and delivery unit for another 268 Korean J Pain Vol. 23, No. 4, 2010
delivery. She again received lumbar epidural analgesia [8]. 
The  third  case  involved  a  31-year-old  woman  with  the 
cervical SCS of CRPS II. She developed severe pain at the 
side of her abdomen at the junction between the electrode 
and the lead extender. This is different from the previously 
reported cases in that the generator was implanted in the 
anterior abdominal wall. The electrode end was placed at 
the T6 level. She developed new severe pain at the side 
of the abdomen at the junction between the epidural lead 
and the lead extender. Therefore, the lead extender was 
surgically cut with the generator switched off during the 
28th week of gestation under local anesthesia. She went 
on to deliver a normal healthy baby at full term [9]. The 
last case, a 35-year-old woman with lumbar SCS for lum-
bosacral  pain  was  admitted  for  an  urgent  caesarean 
section. She had a Mallampati score of III and poor denti-
tion with loose teeth. The electrodes were inserted at L2-3 
and located at T8 and the generator was implanted in the 
left upper buttock. A caesarean delivery was planned, and 
spinal anesthesia was therefore performed below the SCS 
leads at the L4-5 level. A healthy infant was delivered [10]. 
    In our case, the patient received a lumbar SCS im-
plantation with CRPS I. She experienced a missed abortion 
6 weeks after the procedure. There were no significant 
changes in the symptoms of CRPS or in the pattern of pain 
during  pregnancy  or  after  the  abortion.  We  suspected 
three different possible causes for the abortion. First, her 
medications for chronic pain at that time may have been 
the cause [11]. The patient was receiving propranolol, mir-
tazapine, tramadol, solifenacin succinate, mefenamic acid 
(category C; excretion into breast milk unknown), buspir-
one HCl (category B; is not excreted in breast milk), ethyl 
loflazepate, and sodium tianeptine (not available). For cat-
egory C drugs, it is known that "animal studies show some 
fetal risk but or no animal/controlled studies have been 
done." Hence, there is a considerable possibility that these 
d r u g s  m a y  h a v e  b e e n  t h e  c a u s e  o f  t h e  a b o r t i o n  [ 1 2 ] .  
Secondly, a literature search on the use of SCS in humans 
d uring pr egn an cy r et rie v ed on l y one st ud y [13]. Signifi-
cantly elevated human placental lactogen and estriol serum 
levels were found as having a correlation to the onset of 
therapy at a specific week of gestation. This, however, is 
rarely the cause of birth defects or miscarriages. Thirdly, 
t h e  p o s s i b i l i t y  o f  n a t u r a l  a b o r t i o n  m u s t  b e  t a k e n  i n t o  
a c c o u n t .  T h e  o v e r a l l  m i s c a r r i a g e  r a t e  i s  r e p o r t e d  a s  
15-20%, which implies that 15-20% of recognized preg-
nancies result in miscarriage [14].
    The number of cases of SCS implantation continues 
to grow, and it is important to realize that there is always 
the chance to encounter a pregnant patient. The possibility 
o f  m i s s e d  a b o r t i o n ,  a s  m e n t i o n e d  p r e v i o u s l y ,  a n d  o t h e r 
considerable facts related to pregnancy and delivery must 
be realized and kept in mind. 
    Concerning the implantation of SCS, special attention 
must be paid for child-bearing woman. The generator is 
implanted posterior in the flank area away from the belt 
line or in the buttock area to avoid abdomen pain. If the 
patient complains of severe pain at the junction between 
the electrode and the lead extender, simple division of the 
electrode distal to the junction will resolve the problem. 
There is little guidance available regarding the perioper-
ative  anesthetic  management  of  patients  with  SCS,  but 
experience with deep brain stimulators, which use a similar 
technology, may be relevant [15-17]. Artifacts on electro-
c a r d i o g r a p h y  h a v e  b e e n  n o t e d  d u r i n g  S C S ,  d e e p  b r a i n  
stimulation and transcutaneous nerve stimulation [18]. The 
current location of the electrode, lead extender and gen-
erator is ascertained by previous radiographs to assess the 
need for any special measures if neuraxial anesthesia is 
indicated.  However,  the  location  of  the  electrodes  can 
change significantly. Thus, real-time ultrasound examina-
tions may be useful. Potential risks include damage to the 
electrodes due to the spinal or epidural needle, introducer 
or catheter. If neuraxial anesthesia is performed, a metic-
ulous  sterile  technique  is  essential.  Although  regional 
techniques are currently widely accepted, if possible gen-
eral anesthesia is considered to be a better method in pa-
tients with SCS. Surgical diathermy or electrocautery can 
damage the lead insulation, cause temporary suppression 
of the neurostimulator output, and lead to reprogramming 
of the neurostimulator [8,15]. Monopolar diathermy should 
be avoided when possible in the presence of SCS, as pain-
ful electrical shocks have been reported; such shocks have 
not been described with generator turned off or when bi-
polar diathermy is used. Bipolar diathermy appears to be 
safe  if  all  components  are  distant  from  the  implanted 
equipment [16].
    Above all, a good outcome requires a multidisciplinary 
t e a m  a p p r o a c h ,  i n c l u d i n g  o b s t e t r i c s ,  n e o n a t o l o g y ,  p a i n  
medicine and anesthesia, as was used in an earlier preg-
nancy in our case. This will allow sufficient time to proceed 
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We believe that there must be a guideline concerning the 
treatment of chronic pain in patients expecting a future 
pregnancy. These patients must be informed that SCS de-
vice implantation can replace the disadvantages of using 
teratogenic analgesics. In addition, postpartum follow-up, 
w i t h  s p e c i a l  e m p h a s i s  o n  t h e  S C S  f u n c t i o n ,  m u s t  b e  
documented. Informed consent should be obtained regard-
ing the possibility of disrupting the function of the SCS and 
due to infection risk. Postoperatively, the clinical efficacy 
of SCS should be checked by the neurostimulator as any 
d e v i c e  o r  p r o g r a m m i n g  i s s u e s  c a n  b e  i d e n t i f i e d  i n  t h i s 
manner. Most importantly, cautious follow up visits to the 
obstetric department throughout the pregnancy are abso-
lutely necessary.
    In conclusion, SCS is not recommended in pregnancy 
because  the  effects  of  SCS  on  pregnancy  and  nursing 
mothers have not been studied. However, many female pa-
tients suffering from chronic pain may expect future preg-
nancy, and we think that they must be informed about the 
possibility of pregnancy and the effects of the SCS device 
implantation during the course of their pregnancy. We also 
hope that this report will elicit the interest of physicians 
to report other cases involving the conception, pregnancy, 
and labor management of patients with spinal cord stim-
ulators in order to confirm the safety of this modality un-
der these circumstances.
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